The Precision Oncology Scientific Lead acts as the expert / consultant on Companion Diagnostics(CDx) topics in a given country / group of countries, supports local team strategy and clinical CDx development, as well as, patient access and launch of CDx for drug products.
Collaborate with local teams on consolidation of Novartis’s market position by providing key strategic and medical information of CDx compounds and indications and collaborates closely with other departments and external stakeholders in the field.
CDx Access / Treatment Guidelines :
Drive CDx’ penetration in national access policies and treatment guidelines (jointly with Market Access / Public Affairs and Medical Affairs respectively) and support elaboration of Payers solutions’ offers as well as respective stakeholder negotiations.
Customer facing :
Build / develop sustainable relationships w / pathologists, molecular biologists, other CDx providers; lead / develop / execute account-based.
Provide strategic inputs for local CDx plan development for key oncology centers, assist with expertise to support local team in education of CDx providers on CDx requirements for targeted therapies, providing clinical & technical info on the stratifying biomarkers incl.
testing specifics w / NVS global CDx programs & clinical trials; together with local teams ensure timely & broad availability of high-quality CDx tests for NVS drugs;
position NVS Onco as partner in Precision Onco by supporting organization CDx symposia / advisory boards & local / national pathology / CDx conventions;
ensure transfer of diagnostic knowledge between local teams, global CS (correlative science), CDx teams & local external stakeholders;
follow developments on new targets & biomarkers w / NVS pipeline & competitive landscape.
Support local team to build and sustain networks among key medical stakeholders, e.g. pathologists and to work with labs on quality assurance (referral, testing process).
Establish and maintain relationship with key diagnostic partners cross-countries.
Novartis internal Strategic leadership of Precision Oncology strategy & content (biomarker testing / CDx) within Onco matrix across countries & functions & indications;
responsible for biomarker and CDx expertise in DA; develop / roll-out CDx training / info materials; support local teams in representation of biomarker testing for NVS targeted agents in national diagnostic guidelines;
champion quality assurance in CDx, collaborating w / int / external stakeholders; foster field-based CDx learnings for local market pre / post-launch preparation, enhance medical research & educate about NVS clinical research;
ensure Precision Onco input into local NVS planning processes; closely monitor delivery against targets & cost; give strategic guidance on diagnostic tactics / projects, sharing / considering info on global / regional / cluster CDx strategy, collect input from x-country external stakeholders and provide input to Cluster / ORE / Global CDx plans & activities;
provide strategic guidance on diagnostic tactics / projects, sharing / considering info on global correlative science strategy, activities & input from ext stakeholders;
assist local team to support TMO taskforce by site selection & following activities for Phase I trials w / local testing needs;
share info / answer local inquiries on new diagnostic methodologies.
What you’ll bring to the role
Practical experience in molecular diagnostics or pathology or similar
At least 2 yrs. within pharmaceutical or diagnostic industry, incl. customer-facing scientific interaction Bachelor's Degree (preferably in Life Sciences, Pharmacy or Business related discipline) or master’s degree in scientific, economics or business.
Knowledge of CDx in Oncology
Languages : Greek and English fluent
Coaching and leadership : Develop and motivate direct reports and build collaborative and effective team environment.
Mind-set : Organizational agility, building trust, priority setting, driving results and learning on the fly, proactive, solution oriented.
Curiosity : True interest in understanding and contributing in CDx regulatory & policy shaping, treatment guidelines, HTA dossiers and payers negotiations
Strong collaboration with various internal and external stakeholders.
Digital savviness : Open-minded to new ways of working to identify solutions delivered via new technologies and to further evolve an innovative business model.
Problem solving / Analytical thinking : Ability to understand the hidden obstacles in the patient journeys beyond the obvious.